SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

Intracellular Pathways 

Prev Next
Previous

Antitumor Pathways (CNTO 328)

medical illustration of Numerous intracellular pathways of tumor cells are being explored as delivery routes for new drug therapies designed to interrupt tumor cell replication by preventing angiogenesis and cell division.
Next medical illustration of ADAMTS13 is an enzyme produced by the vascular endothelium that cleaves von Willebrand Factor, a protein that mediates platelet adhesion and aggregation at sites of vascular injury. Deficient levels of ADAMTS13 allows platelets to bind to uncleaved von Willebrand Factor multimers and leads to thrombotic microangiopathy.

Severe ADAMTS13 Deficiency

Numerous intracellular pathways of tumor cells are being explored as delivery routes for new drug therapies designed to interrupt tumor cell replication by preventing angiogenesis and cell division.

Keywords: Airbrush, Color, 3D, Advertising / Marketing, Biotechnology, Cell biology / Histology, Pharmacology, Oncology

© Edmond Alexander